Vor Biopharma Inc. Common Stock
Symbol: VOR (NASDAQ)
39.69
▼ (-18.53%) -9.027
Company Description:
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Key Stats
- Today's Open: $47.14
- Today's High: $50.31
- Today's Low: $38.778
- Today's Volume: 851.55K
- Yesterday Close: $48.72
- Yesterday High: $49.95
- Yesterday Low: $41.18
- Yesterday Volume: 1.11M
- Last Min Volume: 2.98K
- Last Min High: $39.62
- Last Min Low: $39.62
- Last Min VWAP: $39.62
Company Profile
- Name: Vor Biopharma Inc. Common Stock
- Website: https://www.vorbio.com
- Listed Date: 2021-02-05
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001817229
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $333.92M
- Round Lot: 100
- Outstanding Shares: 6.85M
- Asset Type: CS
RECENT FILINGS FOR VOR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | SCHEDULE 13G | View |
| 2025-09-25 | SCHEDULE 13G | View |
| 2025-09-24 | S-8 | View |
| 2025-09-24 | S-3 | View |
| 2025-09-23 | SCHEDULE 13G | View |
| 2025-09-22 | 4 | View |
| 2025-09-19 | SCHEDULE 13D/A | View |
| 2025-09-18 | 4 | View |
| 2025-09-17 | 8-K | View |
| 2025-09-15 | 4 | View |
| 2025-09-12 | SCHEDULE 13D/A | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-09 | SCHEDULE 13D/A | View |
| 2025-09-08 | 3 | View |
| 2025-09-05 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-29 | SCHEDULE 13D/A | View |
Latest News on VOR